Estudio piloto: costos directos atribuibles al tabaquismo en dos hospitales de Santiago / Pilot study: tobacco-attributable direct costs in two hospitais in Santiago, Chile
Rev. méd. Chile
;
136(10): 1281-1287, Oct. 2008. tab
Article
Dans Espagnol
| LILACS
| ID: lil-503895
ABSTRACT
Background:
Tobaceo is the fourth cause of the global burden of disease, accounting for 79.9 million loss of disability-adjusted Ufe years (DALYs) in 2001. In 2002, tobacco-attributable mortality in Chile represented 17 percent of total mortality.Aim:
To estimate the direct cost of tobaceo in Ischemic Heart Disease, Chronic Obstructive Pulmonary Disease and Lung Cáncer, explore patients' disposition to answer a health related expenses questionnaire, valídate the instruments used and determine an adequate sample size for an upcoming study. Material andmethods:
Socio-demographic and health care related variables were investigated among patients attending two publie hospitais for ischemic heart disease, chronic obstructive pulmonary disease and lung cancer, in a cross-sectional study. Costs were estimated using the national publie health insurance price list and market pnces. Tobacco-attributable fraction was then applied to calcúlate the tobacco-attributable cost ofeach disease.Results:
The instruments used were validated. The group of lung cáncer patients was smaller due to increased mortality prior to interview. Lung cancer generated the largest total and attríbutable direct costs. The costs in patients with ischemic heart disease were significantly lowerConclusions:
There were some difficulties in the application of the questionnaire to register medication use. The sample size needed in a larger study was calculated for each of the three diseases. We recommend that a definitive study addresses tobacco-attributable direct costs related to chronic obstructive pulmonary disease.
Texte intégral:
Disponible
Indice:
LILAS (Amériques)
Sujet Principal:
Fumer
/
Dépenses de santé
/
Ischémie myocardique
/
Broncho-pneumopathie chronique obstructive
/
Tumeurs du poumon
Type d'étude:
Essai clinique contrôlé
/
Évaluation en économique de la santé
/
Étude observationnelle
/
Étude de prévalence
/
Facteurs de risque
Limites du sujet:
Adulte très âgé
/
Femelle
/
Humains
/
Mâle
Pays comme sujet:
Amérique du Sud
/
Chili
langue:
Espagnol
Texte intégral:
Rev. méd. Chile
Thème du journal:
Médicament
Année:
2008
Type:
Article
/
descriptif de projet
Pays d'affiliation:
Chili
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS